Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro

International Journal of Cancer

Volumn 72, Issue 1, 1997, Pages 149-154

  Okamoto, Masato ^a   Hattori, Kazunori ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 6; RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GROWTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ANTIBODIES, BLOCKING; ANTIGENS, CD; CELL DIVISION; CYTOKINE RECEPTOR GP130; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0030848304     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D     Document Type: Article

References (21)

1. BORSELLINO, N., BELLDEGRUN, A. and BONAVIDA, B., Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposidemediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res., 55, 4633-4639 (1995).
2. DE REIJKE, T.M., Vos, P.C.N., DE VOER, E.C., BEVERS, R.F.M., DE MUINCK KEIZER, W.H., KURTH, K.H. and SCHAMHART, D.H.J., Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG). Urol. Res., 21, 349-352 (1993).
3. EUSTACE, D., HAN, X., GOODING, R., ROWBOTTOM, A., RICHES, P. and HEYDERMAN, E., Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol., 50, 15-19 (1993).
4. HALBERT, C.L., DEMERS, G.W. and GALLOWAY, D.A., The E6 and E7 genes Of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol., 66, 2125-2134 (1992).
5. KAWAI, K., KAWAMATA, H., KAMEYAMA, S., RADEMAKER, A. and OYASU, R., Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus. Cancer Res., 54, 2630-2632 (1994).
6. KAWAI, K., YAMAMOTO, M., KAMEYAMA, S., KAWAMATA, H., RADEMAKER, A. and OYASU, R., Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation. Cancer Res., 53, 5172-5175 (1993).
7. KISHIMOTO, T., The biology of interleukin-6. Blood, 74, 1-10 (1989).
8. Lu, C. and KERBEL, R.S., Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progres-sion. J. Cell Biol., 120, 1281-1288 (1993).
9. MEYERS, F.J., GUMERLOCK, P.H., KAWASAKI, E.S., WANG, A.M., DE VERE WHITE, R.W. and ERLICH, H.A., Bladder cancer; human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer, 67, 2087-2095 (1991).
10. MIKI, S., IWANO, M., MIKI, Y., YAMAMOTO, M., TANG, B., YOKOKAWA, K., SONODA, T., HIRANO, T. and KISHIMOTO, T., Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett., 250, 607-610 (1989).
11. OKAMOTO, M., KAWAI, K., REZNIKOFF, C.A. and OYASU, R., Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide. Cancer Res., 56, 4649-4653 (1996).
12. OKAMOTO, M., KAWAMATA, H., KAWAI, K. and OYASU, R., Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin-6. Cancer Res., 55, 4581-4585 (1995).
13. OKAMOTO, M., LEE, C. and OYASU, R., Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res., 57, 141-146 (1997).
14. OKAMOTO, M. and OYASU, R., Effect of transfected interleukin-6 in non-tumorigenic and tumorigenic rat urothelial cell lines. Int. J. Cancer, 68, 616-621 (1996).
15. RAWLE, F.C., SHIELDS, J., SMITH, S.H., ILIESCU, V., MERKENSCHLAGER, M., BEVERLEY, P.C.L. and CALLARD, R.E., B cell growth and differentiation induced by supernatants of transformed epithelial cell lines. Europ: J. Immunol., 16, 1017-1019 (1986).
16. REZNIKOFF, C.A., JOHNSON, M.D., NORBACK, D.H. and BRYAN, G.T., Growth and characterization of normal human urothelium in vitro. In Vitro, 19, 326-343 (1983).
17. SEGUCHI, T., YOKOKAWA, K., SUGAO, H., NAKANO, E., SONODA, T. and OKUYAMA, A., Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J. Urol., 148, 791-794 (1992).
18. TAKENAWA, J., KANEKO, Y., FUKUMOTO, M., FUKATSU, A., HIRANO, T., FUKUYAMA, H., NAKAYAMA, H., FUJITA, J. and YOSHIDA, O., Enhanced expression of interleukin-6 in primary human renal carcinomas. J. nat. Cancer Inst., 83, 1668-1672 (1991).
19. TAM, I., CARDINALE, I., KRUEGER, J., MURPHY, J.S., MAY, L.T. and SEHGAL, P.B., Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. exp. Med., 170, 1649-1669 (1989).
20. YAMAMOTO, M., Wu, H., MOMOSE, H., RADEMAKER, A. and OYASU, R., Marked enhancement of rat urinary bladder carcinogenesis by heat-killed Escherichia coli. Cancer Res., 52, 5329-5333 (1992).
21. YAMASAKI, K., TAGA, T., HIRATA, Y., YAWATA, H., KAWANISHI, Y, SEED, B., TANIGUCHI, T., HIRANO, T. and KISHIMOTO, T., Cloning and expression of the human interleukin-6 (BSF-2/IFNβ 2) receptor. Science, 241, 825-828 (1988).